BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 35967347)

  • 1. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.
    Lewinsohn DA; Winata E; Swarbrick GM; Tanner KE; Cook MS; Null MD; Cansler ME; Sette A; Sidney J; Lewinsohn DM
    PLoS Pathog; 2007 Sep; 3(9):1240-9. PubMed ID: 17892322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis.
    Esin S; Batoni G; Saruhan-Direskeneli G; Harris RA; Grunewald J; Pardini M; Svenson SB; Campa M; Wigzell H
    Infect Immun; 1999 Aug; 67(8):3800-9. PubMed ID: 10417141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.
    Nilsson JB; Kaabinejadian S; Yari H; Kester MGD; van Balen P; Hildebrand WH; Nielsen M
    Sci Adv; 2023 Nov; 9(47):eadj6367. PubMed ID: 38000035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
    Musvosvi M; Huang H; Wang C; Xia Q; Rozot V; Krishnan A; Acs P; Cheruku A; Obermoser G; Leslie A; Behar SM; Hanekom WA; Bilek N; Fisher M; Kaufmann SHE; Walzl G; Hatherill M; Davis MM; Scriba TJ; ;
    Nat Med; 2023 Jan; 29(1):258-269. PubMed ID: 36604540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice.
    Mortensen R; Clemmensen HS; Woodworth JS; Therkelsen ML; Mustafa T; Tonby K; Jenum S; Agger EM; Dyrhol-Riise AM; Andersen P
    Commun Biol; 2024 May; 7(1):662. PubMed ID: 38811662
    [No Abstract]   [Full Text] [Related]  

  • 6. Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis.
    Abay Z; Sadikalieva S; Shorayeva K; Yespembetov B; Sarmykova M; Jekebekov K; Tokkarina G; Absatova Z; Kalimolda E; Shayakhmetov Y; Moldagulova S; Issabek A; Kopeyev S; Omurtay A; Barakbayev K; Kassenov M; Syrym N; Abduraimov Y; Zakarya K; Nurpeisova A
    J Genet Eng Biotechnol; 2023 Oct; 21(1):99. PubMed ID: 37823960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.
    Gao RQ; Sun JH; Ma YH; Xie YW; Shao GM; Wang C; Tan B; Liu K; Li K; Li N; Hu WY; Cao J
    J Oncol; 2023; 2023():1875153. PubMed ID: 36873738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens for CD4 and CD8 T cells in tuberculosis.
    Lindestam Arlehamn CS; Lewinsohn D; Sette A; Lewinsohn D
    Cold Spring Harb Perspect Med; 2014 May; 4(7):a018465. PubMed ID: 24852051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4
    Lee YH; Hyun YS; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
    Front Immunol; 2022; 13():897781. PubMed ID: 35967347
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8
    Jo HA; Hyun SJ; Hyun YS; Lee YH; Kim SM; Baek IC; Sohn HJ; Kim TG
    Immune Netw; 2023 Apr; 23(2):e17. PubMed ID: 37179751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of CD4
    Hyun YS; Lee YH; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
    Front Immunol; 2021; 12():774491. PubMed ID: 35069546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
    Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.
    Mustafa AS; Shaban FA; Al-Attiyah R; Abal AT; El-Shamy AM; Andersen P; Oftung F
    Scand J Immunol; 2003 Feb; 57(2):125-34. PubMed ID: 12588658
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.